Annual Total Expenses
$225.35 M
-$106.94 M-32.18%
31 December 2023
Summary:
Nektar Therapeutics annual total expenses is currently $225.35 million, with the most recent change of -$106.94 million (-32.18%) on 31 December 2023. During the last 3 years, it has fallen by -$307.49 million (-57.71%). NKTR annual total expenses is now -59.37% below its all-time high of $554.65 million, reached on 31 December 2019.NKTR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$58.42 M
-$1.55 M-2.59%
30 September 2024
Summary:
Nektar Therapeutics quarterly total expenses is currently $58.42 million, with the most recent change of -$1.55 million (-2.59%) on 30 September 2024. Over the past year, it has increased by +$775.00 thousand (+1.34%). NKTR quarterly total expenses is now -60.77% below its all-time high of $148.91 million, reached on 31 March 2019.NKTR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.2% | +1.3% |
| 3 y3 years | -57.7% | -57.8% |
| 5 y5 years | -55.4% | -54.3% |
NKTR Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.9% | at low | -58.2% | +7.1% |
| 5 y | 5 years | -59.4% | at low | -59.3% | +7.1% |
| alltime | all time | -59.4% | +2945.2% | -60.8% | >+9999.0% |
Nektar Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $58.42 M(-2.6%) |
| June 2024 | - | $59.97 M(+6.9%) |
| Mar 2024 | - | $56.09 M(+2.8%) |
| Dec 2023 | $225.35 M(-32.2%) | $54.55 M(-5.4%) |
| Sept 2023 | - | $57.65 M(+5.7%) |
| June 2023 | - | $54.54 M(-6.9%) |
| Mar 2023 | - | $58.61 M(-6.8%) |
| Dec 2022 | $332.29 M(-39.4%) | $62.91 M(+3.0%) |
| Sept 2022 | - | $61.10 M(-10.6%) |
| June 2022 | - | $68.38 M(-51.1%) |
| Mar 2022 | - | $139.91 M(+1.4%) |
| Dec 2021 | $548.01 M(+2.8%) | $137.92 M(-0.4%) |
| Sept 2021 | - | $138.52 M(-0.0%) |
| June 2021 | - | $138.53 M(+4.1%) |
| Mar 2021 | - | $133.04 M(-0.9%) |
| Dec 2020 | $532.84 M(-3.9%) | $134.18 M(+0.8%) |
| Sept 2020 | - | $133.08 M(+5.2%) |
| June 2020 | - | $126.56 M(-9.0%) |
| Mar 2020 | - | $139.01 M(-3.1%) |
| Dec 2019 | $554.65 M(+9.7%) | $143.50 M(+12.1%) |
| Sept 2019 | - | $127.96 M(-4.7%) |
| June 2019 | - | $134.28 M(-9.8%) |
| Mar 2019 | - | $148.91 M(+6.3%) |
| Dec 2018 | $505.39 M(+43.8%) | $140.12 M(+10.9%) |
| Sept 2018 | - | $126.40 M(+10.8%) |
| June 2018 | - | $114.12 M(-8.5%) |
| Mar 2018 | - | $124.76 M(+20.5%) |
| Dec 2017 | $351.37 M(+26.3%) | $103.52 M(+24.1%) |
| Sept 2017 | - | $83.44 M(-2.1%) |
| June 2017 | - | $85.25 M(+7.7%) |
| Mar 2017 | - | $79.17 M(+13.7%) |
| Dec 2016 | $278.29 M(+7.0%) | $69.60 M(+0.5%) |
| Sept 2016 | - | $69.24 M(-2.6%) |
| June 2016 | - | $71.09 M(+4.0%) |
| Mar 2016 | - | $68.37 M(-0.5%) |
| Dec 2015 | $260.15 M(+19.8%) | $68.73 M(+15.5%) |
| Sept 2015 | - | $59.53 M(-10.0%) |
| June 2015 | - | $66.13 M(+0.6%) |
| Mar 2015 | - | $65.76 M(+15.3%) |
| Dec 2014 | $217.19 M(-19.3%) | $57.04 M(+8.5%) |
| Sept 2014 | - | $52.55 M(+2.2%) |
| June 2014 | - | $51.43 M(-8.4%) |
| Mar 2014 | - | $56.17 M(-16.2%) |
| Dec 2013 | $269.05 M(+21.9%) | $67.04 M(-0.6%) |
| Sept 2013 | - | $67.43 M(+1.5%) |
| June 2013 | - | $66.47 M(-2.4%) |
| Mar 2013 | - | $68.11 M(+5.5%) |
| Dec 2012 | $220.72 M(+12.9%) | $64.53 M(+25.8%) |
| Sept 2012 | - | $51.31 M(+1.3%) |
| June 2012 | - | $50.67 M(-6.5%) |
| Mar 2012 | - | $54.21 M(+7.9%) |
| Dec 2011 | $195.42 M(+11.8%) | $50.25 M(+3.8%) |
| Sept 2011 | - | $48.41 M(-6.2%) |
| June 2011 | - | $51.59 M(+14.2%) |
| Mar 2011 | - | $45.17 M(-15.2%) |
| Dec 2010 | $174.72 M(+4.6%) | $53.28 M(+20.7%) |
| Sept 2010 | - | $44.15 M(+8.5%) |
| June 2010 | - | $40.70 M(+11.2%) |
| Mar 2010 | - | $36.59 M(-17.8%) |
| Dec 2009 | $167.06 M | $44.50 M(+13.9%) |
| Sept 2009 | - | $39.08 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $43.47 M(+8.6%) |
| Mar 2009 | - | $40.01 M(<-9900.0%) |
| Dec 2008 | $171.38 M(-44.6%) | -$261.00 K(-100.5%) |
| Sept 2008 | - | $56.00 M(+4.2%) |
| June 2008 | - | $53.76 M(-13.1%) |
| Mar 2008 | - | $61.88 M(+118.0%) |
| Dec 2007 | $309.18 M(-18.0%) | $28.39 M(-62.6%) |
| Sept 2007 | - | $75.89 M(-19.2%) |
| June 2007 | - | $93.91 M(-15.4%) |
| Mar 2007 | - | $110.98 M(+0.8%) |
| Dec 2006 | $376.95 M(+25.2%) | $110.07 M(+35.4%) |
| Sept 2006 | - | $81.31 M(-34.1%) |
| June 2006 | - | $123.44 M(+98.7%) |
| Mar 2006 | - | $62.13 M(-53.5%) |
| Dec 2005 | $301.05 M(+60.0%) | $133.75 M(+124.0%) |
| Sept 2005 | - | $59.72 M(+8.6%) |
| June 2005 | - | $55.00 M(+4.6%) |
| Mar 2005 | - | $52.59 M(+5.7%) |
| Dec 2004 | $188.21 M(+9.1%) | $49.77 M(+5.0%) |
| Sept 2004 | - | $47.37 M(-4.6%) |
| June 2004 | - | $49.64 M(+19.2%) |
| Mar 2004 | - | $41.64 M(-8.6%) |
| Dec 2003 | $172.44 M(-11.5%) | $45.53 M(+9.7%) |
| Sept 2003 | - | $41.49 M(-2.0%) |
| June 2003 | - | $42.35 M(-1.7%) |
| Mar 2003 | - | $43.07 M(-17.0%) |
| Dec 2002 | $194.93 M(+3.6%) | $51.87 M(+8.5%) |
| Sept 2002 | - | $47.80 M(+6.4%) |
| June 2002 | - | $44.93 M(-10.7%) |
| Mar 2002 | - | $50.33 M(-11.7%) |
| Dec 2001 | $188.17 M(+63.0%) | $56.97 M(+11.9%) |
| Sept 2001 | - | $50.90 M(+18.5%) |
| June 2001 | - | $42.94 M(+14.9%) |
| Mar 2001 | - | $37.37 M(+20.6%) |
| Dec 2000 | $115.48 M(+60.5%) | $30.98 M(+3.3%) |
| Sept 2000 | - | $30.00 M(+3.1%) |
| June 2000 | - | $29.09 M(+14.5%) |
| Mar 2000 | - | $25.40 M(+9.7%) |
| Dec 1999 | $71.95 M(+64.3%) | $23.15 M(+26.5%) |
| Sept 1999 | - | $18.30 M(+10.9%) |
| June 1999 | - | $16.50 M(+18.0%) |
| Mar 1999 | - | $13.98 M(+6.0%) |
| Dec 1998 | $43.78 M(+46.1%) | $13.19 M(+23.2%) |
| Sept 1998 | - | $10.70 M(+0.3%) |
| June 1998 | - | $10.67 M(+16.7%) |
| Mar 1998 | - | $9.14 M(+0.6%) |
| Dec 1997 | $29.97 M(+62.9%) | $9.09 M(+16.9%) |
| Sept 1997 | - | $7.77 M(+8.5%) |
| June 1997 | - | $7.16 M(+20.9%) |
| Mar 1997 | - | $5.92 M(-1.3%) |
| Dec 1996 | $18.40 M(+50.8%) | $6.00 M(+33.3%) |
| Sept 1996 | - | $4.50 M(+2.3%) |
| June 1996 | - | $4.40 M(+22.2%) |
| Mar 1996 | - | $3.60 M(+9.1%) |
| Dec 1995 | $12.20 M(+64.9%) | $3.30 M(+10.0%) |
| Sept 1995 | - | $3.00 M(0.0%) |
| June 1995 | - | $3.00 M(+3.4%) |
| Mar 1995 | - | $2.90 M(0.0%) |
| Dec 1994 | $7.40 M | $2.90 M(+70.6%) |
| Sept 1994 | - | $1.70 M(+21.4%) |
| June 1994 | - | $1.40 M(0.0%) |
| Mar 1994 | - | $1.40 M |
FAQ
- What is Nektar Therapeutics annual total expenses?
- What is the all time high annual total expenses for Nektar Therapeutics?
- What is Nektar Therapeutics annual total expenses year-on-year change?
- What is Nektar Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly total expenses year-on-year change?
What is Nektar Therapeutics annual total expenses?
The current annual total expenses of NKTR is $225.35 M
What is the all time high annual total expenses for Nektar Therapeutics?
Nektar Therapeutics all-time high annual total expenses is $554.65 M
What is Nektar Therapeutics annual total expenses year-on-year change?
Over the past year, NKTR annual total expenses has changed by -$106.94 M (-32.18%)
What is Nektar Therapeutics quarterly total expenses?
The current quarterly total expenses of NKTR is $58.42 M
What is the all time high quarterly total expenses for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly total expenses is $148.91 M
What is Nektar Therapeutics quarterly total expenses year-on-year change?
Over the past year, NKTR quarterly total expenses has changed by +$775.00 K (+1.34%)